Want to join the conversation?
$ADT's recurring revenue, which accounts for about 93% of its total revenue, grew 2% in 4Q15 as it added different products and services to the portfolio in place of lower margin one-time sales. In 2016, $ADT expects to grow non-recurring revenue due to traction in commercial channel and broadening of its service capabilities and product offerings.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?